Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Improving the outcome of liver transplantation with very old donors with updated selection and management criteria.

Cescon M, Grazi GL, Cucchetti A, Ravaioli M, Ercolani G, Vivarelli M, D'Errico A, Del Gaudio M, Pinna AD.

Liver Transpl. 2008 May;14(5):672-9. doi: 10.1002/lt.21433.

2.

[Old donors in liver transplantation for chronic hepatitis C].

Aguilera V, Ponce M, Berenguer M, Moreno R, Rayón JM, Sanjuán F, Prieto M, Mir J.

Rev Esp Enferm Dig. 2007 Oct;99(10):581-7. Spanish.

3.

Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.

Selzner M, Kashfi A, Selzner N, McCluskey S, Greig PD, Cattral MS, Levy GA, Lilly L, Renner EL, Therapondos G, Adcock LE, Grant DR, McGilvray ID.

Liver Transpl. 2009 Oct;15(10):1288-95. doi: 10.1002/lt.21828.

4.

Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.

Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW Jr, Langnas AN.

Liver Int. 2007 Aug;27(6):758-63.

PMID:
17617118
5.

Use of severely steatotic grafts in liver transplantation: a matched case-control study.

McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA.

Ann Surg. 2007 Dec;246(6):940-6; discussion 946-8.

PMID:
18043095
6.

Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.

Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, Garcia-Valdecasas JC, Salizzoni M, Moreno GE, Mirza D.

Transplantation. 2006 Jan 15;81(1):7-14.

PMID:
16421468
7.

The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.

Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, Upton MP, Reyes JD, Perkins JD.

Liver Transpl. 2010 Jul;16(7):874-84. doi: 10.1002/lt.22085.

8.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

9.

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.

Liver Transpl. 2009 Jun;15(6):619-28. doi: 10.1002/lt.21761.

10.

[The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].

Boin Ide F, Leonardi MI, Udo EY, Sevá-Pereira T, Stucchi RS, Leonardi LS.

Arq Gastroenterol. 2008 Oct-Dec;45(4):275-83. Portuguese.

11.

The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.

Yagci G, Fernandez LA, Knechtle SJ, D'Alessandro AM, Chin LT, Musat AI, Lucey MR, Said A, Pirsch JD, Leverson G, Kalayoglu M.

Transplant Proc. 2008 Jan-Feb;40(1):219-23. doi: 10.1016/j.transproceed.2007.11.058.

PMID:
18261591
12.

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.

Liver Transpl. 2007 May;13(5):733-40.

13.

Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: a single-center experience.

Gruttadauria S, Vizzini G, Biondo D, Mandalà L, Volpes R, Palazzo U, Gridelli B.

Liver Transpl. 2008 Feb;14(2):220-7. doi: 10.1002/lt.21359.

14.

The clinical relevance of the anhepatic phase during liver transplantation.

Ijtsma AJ, van der Hilst CS, de Boer MT, de Jong KP, Peeters PM, Porte RJ, Slooff MJ.

Liver Transpl. 2009 Sep;15(9):1050-5. doi: 10.1002/lt.21791.

15.

Using elderly donors in liver transplantation.

Grazi GL, Ravaioli M, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Lauro A, Ramacciato G, Pinna AD.

Transplant Proc. 2005 Jul-Aug;37(6):2582-3.

PMID:
16182750
16.

Contribution of marginal donors to liver transplantation for hepatitis C virus infection.

Briceño J, Ciria R, Pleguezuelo M, Naranjo A, Sánchez-Hidalgo J, Ruiz-Rabelo J, López-Cillero P, Luque A, de la Mata M, Rufián S.

Transplant Proc. 2007 Sep;39(7):2297-9.

PMID:
17889169
17.

Advanced donor age alone does not affect patient or graft survival after liver transplantation.

Anderson CD, Vachharajani N, Doyle M, Lowell JA, Wellen JR, Shenoy S, Lisker-Melman M, Korenblat K, Crippin J, Chapman WC.

J Am Coll Surg. 2008 Dec;207(6):847-52. doi: 10.1016/j.jamcollsurg.2008.08.009. Epub 2008 Oct 2.

PMID:
19183530
18.

Transplantation of liver grafts from older donors: impact on recipients with hepatitis C virus infection.

Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Bozorgzadeh A.

Transplant Proc. 2005 Sep;37(7):3162-4.

PMID:
16213337
19.

Liver transplantation following donation after cardiac death: an analysis using matched pairs.

Pine JK, Aldouri A, Young AL, Davies MH, Attia M, Toogood GJ, Pollard SG, Lodge JP, Prasad KR.

Liver Transpl. 2009 Sep;15(9):1072-82. doi: 10.1002/lt.21853.

20.

Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors.

Chan EY, Olson LC, Kisthard JA, Perkins JD, Bakthavatsalam R, Halldorson JB, Reyes JD, Larson AM, Levy AE.

Liver Transpl. 2008 May;14(5):604-10. doi: 10.1002/lt.21361.

Supplemental Content

Support Center